A Systemic Immune Inflammation Index and PD-L1 (SP142) Expression as a Potential Combined Biomarker of the Clinical Benefit of Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer
Article in Journal of Clinical Medicine (March 2024)
The most recent citing publications are shown below. View all 72 publications that cite this research output on Dimensions.
Article in Journal of Clinical Medicine (March 2024)
Article in Signal Transduction and Targeted Therapy (March 2024)
Article in Molecular Cancer (February 2024)